EMEA-001973-PIP01-16

Key facts

Active substance
Teprotumumab
Decision number
P/0345/2016
PIP number
EMEA-001973-PIP01-16
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
Treatment of active thyroid eye disease
Route(s) of administration
Intravenous use
Contact for public enquiries
River Vision Development Corporation
United States
E-mail: rivervision@narrowrivermgmt.com 
Tel.: +212 5828400
Fax: +212 5828404
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating